Šalis: Didžioji Britanija
kalba: anglų
Šaltinis: MHRA (Medicines & Healthcare Products Regulatory Agency)
Ascorbic acid; Glucosamine sulfate
Health+Plus Ltd
n/a
Ascorbic acid; Glucosamine sulfate
Oral tablet
No Controlled Drug Status
Valid as a prescribable product
BNF: 09120000; GTIN: 5060025251844
PACKAGE LEAFLET: INFORMATION FOR THE USER GLUCOSAMINE 625 MG & 1250 MG EFFERVESCENT TABLETS Glucosamine READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor, pharmacist or nurse. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Glucosamine is and what it is used for 2. What you need to know before you take Glucosamine 3. How to take Glucosamine 4. Possible side effects 5. How to store Glucosamine 6. Contents of the pack and other information 1. WHAT GLUCOSAMINE IS AND WHAT IT IS USED FOR Glucosamine can improve mobility and relieve pain in the knee. You can use Glucosamine for the relief of symptoms in mild to moderate osteoarthritis of the knee. Glucosamine is not suitable for treatment of acute pain. If your doctor has prescribed Glucosamine for a different use, always follow your doctor’s advice. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE GLUCOSAMINE DO NOT TAKE GLUCOSAMINE − if you are allergic to glucosamine or any of the other ingredients of this medicine (listed in section 6). − if you are allergic to shellfish, as the active substance is extracted from shellfish. WARNINGS AND PRECAUTIONS Talk to your doctor or pharmacist before taking Glucosamine if you: • suffer from diseases related to the heart and blood vessels(cardiovascular), as your cholesterol levels in the blood may increase during your treatment with glucosamine. • suffer from diabetes. Increased monitoring and control of your blood sugar levels may be necessary when you start your treatment with glucosamine. • have asthma, as the symptoms of asthma may worsen after star Perskaitykite visą dokumentą
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Glucosamine 625 mg Effervescent Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each effervescent tablet contains 625 mg glucosamine (as glucosamine hydrochloride). Excipients: Sorbitol (E420) Sodium For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Effervescent tablet. Round, white to almost white effervescent tablets with lemon flavour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Relief of symptoms in mild to moderate osteoarthritis of the knee. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Adults _ 1250 mg per day corresponding to one effervescent tablet Glucosamine 625 mg twice daily or one effervescent tablet Glucosamine 1250 mg once daily. Before intake the effervescent tablets must be dissolved in at least 100 ml water (½ glass) and can be taken independently from meals. Glucosamine is not indicated for the treatment of acute painful symptoms. Relief of symptoms (particularly pain relief) may not be experienced until after several weeks of treatment and in some cases even longer. If pain relief is not achieved after 2-3 months, continued treatment with glucosamine should be re-evaluated. _Elderly _ Dose adjustment is not necessary in treatment of elderly. _Children and Adolescents _ Glucosamine is not recommended for use in children and adolescents below 18 years, due to lack of data on safety and efficacy. _Impaired renal and/or hepatic function _ As no studies have been conducted in patients with impaired renal and/or hepatic function, dosage recommendations cannot be given 4.3 CONTRAINDICATIONS Glucosamine is contraindicated in the following cases: • Hypersensitivity to the active substance_ _ or to any of the excipients listed in section 6.1. • Patients who are allergic to shellfish as the active substance is extracted from shellfish. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Glucosamine should not be used in children and adolescents below the age of 18, due to lack of data on safety and efficacy. A do Perskaitykite visą dokumentą